Clinical Validation of Nerveblox, an Artificial Intelligence Software to Support Ultrasound-Guided Regional Anesthesia Procedures
NCT ID: NCT06878911
Last Updated: 2025-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2025-01-13
2025-02-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Assess the Accuracy of Artificial Intelligence for Ultrasound-guided Regional Anesthesia
NCT05807737
Nerve and Plane Block Data Collection Study for the Development of Artificial Intelligence-assisted Software
NCT06375603
Artificial Intelligence for Ultrasound-Guided Peripheral Nerve and Plane Blocks
NCT05718414
AI-Assisted Ultrasound-Guided Nerve Block: Model Development and Performance Assessment
NCT07171502
Intelligent Needle Tip Tracking Using Ultrasound Imaging for Lumbar Plexus Blocks
NCT03667898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data collection method and Analysis:
A total of 40 healthy subjects were enrolled and scanned by three different expert anesthesiologists. Twelve different peripheral nerve and plane block regions supported by the Nerveblox software were scanned bilaterally. Each participant spent approximately 30 minutes in the ultrasound scanning session, with each ultrasound clip lasting 10 seconds.
Age, gender, weight, and height data were collected and reported for each subject. Subjects were selected to balance the BMI distribution between those with BMI \< 30 kg/m² and those with BMI ≥ 30 kg/m². An FDA-cleared, commercially available ultrasound device was used during the scanning process, and the Nerveblox software was not utilized in the data collection sessions.
Collected ultrasound clips included both ideal and non-ideal block views. The collected ultrasound scans were processed post hoc by the Nerveblox software, and the resulting outputs, alongside the raw ultrasound images, will be assessed by a panel of expert anesthesiologists. These clips were reviewed by two separate groups of reviewers, each consisting of three members.
Reviewers were asked to evaluate:
* Highlighting of Safety-Critical Anatomical Structures: For each safety-critical anatomical landmark on each clip, the majority opinion (at least 2 out of 3) was used to determine the overall panel results.
* Image Quality: Experts rated image quality on a scale from 1 to 5. These results were then converted to a binary measure for analysis.
* Effect of color highlighting on the perceived risks of ultrasound-guided regional anesthesia
Data were expressed as frequencies and shown as a percentage of the total clips analyzed. Inter-rater agreement was reported by block region.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
U.S. Population
Ultrasound Scans
10 seconds scanning for one block region
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound Scans
10 seconds scanning for one block region
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stated willingness to comply with all study procedures and availability for the duration of the study
* In good general health
Exclusion Criteria
* Inability to lie to flat
* Any complaint or anatomical deformity on the regions to be scanned
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smart Alfa Teknoloji San. ve Tic. A.S.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Scott Shwartz, M.D.
Role: PRINCIPAL_INVESTIGATOR
AABP Integrative Pain Care and Wellness Clinic, Brooklyn
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AABP Integrative Pain Care and Wellness Clinic
Brooklyn, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NRV-001-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.